Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study.

Yechezkel, Matan; Mofaz, Merav; Painsky, Amichai; Patalon, Tal; Gazit, Sivan; Shmueli, Erez; Yamin, Dan

Yechezkel, Matan; Mofaz, Merav; Painsky, Amichai; Patalon, Tal; Gazit, Sivan; Shmueli, Erez; Yamin, Dan.

Afiliación

Yechezkel M; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
Mofaz M; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
Painsky A; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
Patalon T; Kahn Sagol Maccabi Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.
Gazit S; Kahn Sagol Maccabi Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.
Shmueli E; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel; Media Lab, MIT, Cambridge, MA, USA.
Yamin D; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel; Center for Combatting Pandemics, Tel Aviv University, Tel Aviv, Israel. Electronic address: dan.yamin@gmail.com.

Lancet Respir Med ; 11(2): 139-150, 2023 02.

Article en En | MEDLINE | ID: mdl-36410364

Asunto(s)

COVID-19; Vacunas; Humanos; Vacuna BNT162; Estudios Retrospectivos; Estudios Prospectivos; COVID-19/prevención & control

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Respir Med Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google